0 By SiteAdmin Vitreo Retinal Diseases July 20, 2017 FP302 : Is Tissue Plasminogen Activator Necessary in Managing Submacular Hemorrhage FP1274 : Safety and Efficacy of Razumab – the New Biosimilar in India : Our Experience Leave a comment Cancel reply Send Comment
